References
- Valent P, Horny H-P, Escribano L, et al Diagnostic criteria and classification of mastocytosis: a consensus proposal, Leuk Res 2001;25:603–625.
- Horny H-P, Soltar K, Sperr R, Valent P. Systemic mastocytosis with associated clonal haematological non-mast cell lineage disease: a histopatological challenge. J Clin Pathol 2004;57:604–608.
- Travis WD, Li CY, Yam LT, Bergstralh EJ, Swee RG. Significance of systemic mast cell disease with associated hematologic disorders. Cancer 2000;62:957–962.
- Sotlar K, Saeger W, Stellmacher F, et al Occult mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis. J Clin Pathol 2006;59:875–878.
- Stellmacher F, Sotlar K, Balleisen L, Valent P, Horny HP. Bone marrow mastocytosis associated with IgM kappa plasma cell myeloma. Leuk Lymphoma 2004;45:801–805.
- Hagen W, Schwarzmeier J, Walchshofer S, et al A case of bone marrow mastocytosis associated with multiple myeloma. Ann Hematol 1998;76:167–174.
- Nagata H, Worobec AS, Oh CK, et al Identification of a point mutation in the catalytic domain of the protooncogene c-KIT in peripherial blood mononuclear cells of patients who have mastocytosis with an associated hematological disorder. Proc Natl Acad Sci USA 1995;92:10560–10564.
- Sotlar K, Escribano L, Landt O, et al One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol 2003;162:737–746.
- Garcia-Montero AC, Jaro-Acevedo M, Teodosio C, et al KIT mutation in the mast cells and other bone marrow hemapoetic cell lineage in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 2006;108:2366–2372.
- Longley BJ, Tyrrell L, Lu SZ, et al Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis establishment of clonality in a human mast cell neoplasm. Nat Genet 1996;12:312–314.
- Chiappetta N, Gruber B. The role of mast cells in osteoporosis. Semin Arthritis Rheum 2006;36:32–36.
- Theoharides TC, Boucher W, Spear K. Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol 2002;128:344–350.
- Sperr WR, Drach J, Hauswirth AW, Ackermann J, Foedinger M, Valent P. Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogenic stem cell transplantation. Clin Cancer Res 2005;11:6787–6792.
- Sperr WR, Horny HP, Valent P. Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis. Int Arch Allergy Immunol 2002;127:140–142.
- Molin D, Fischer M, Xiang Z, et al Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease. Br J Haematol 2001;114:616–623.